DSIJ Mindshare

Multinational pharma company, Cipla posted a 3 per cent hike in its share price as the company received final approval for its new drug application (ANDA) for Efavirenz tablets 600mg from the United States Food and Drug Administration (USFDA).

The share price of pharma major Alembic Pharmaceuticals continued to surge in Friday’s trading session. The share price grew by 7 per cent on Friday as the company bagged EIR for its formulation facility at Panelav, Gujarat from the US Food and Drugs Association. 

The stocks that are likely to record significant movement on the bourses on Friday, June 15 are HIL Limited, Wipro Limited, Maha Rashtra Apex Corporation Limited and Hind Aluminium Industries Limited.  

The share price of Cipla surged by nearly 2 per cent in the early trade on Thursday as the company received the USFDA approval for Isoproterenol Hydrochloride injection, a generic version of Hospira Inc’s Isuprel injection.

Pharma major Alembic Pharmaceuticals bagged the approval of US Food and Drugs Association for its abbreviated new drug application (ANDA) for Doxycycline Hyclate capsules.